Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
News
Sports
TV & Film
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts115/v4/52/3e/19/523e1980-a572-bccc-0d8b-6646c95af132/mza_14606859327868641740.jpg/600x600bb.jpg
Rise Up with Orriant
Orriant
76 episodes
1 day ago
Join Orriant for a journey through wellbeing and population health trends and conversations. Our speakers are national experts in their fields, assisted by Orriant's best-in-class health coaches.
Show more...
Health & Fitness
RSS
All content for Rise Up with Orriant is the property of Orriant and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Join Orriant for a journey through wellbeing and population health trends and conversations. Our speakers are national experts in their fields, assisted by Orriant's best-in-class health coaches.
Show more...
Health & Fitness
https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/2126764/2126764-1755716002648-f0999632d814a.jpg
SEASON 6 - EPISODE 8: THE TRUTH ABOUT GLP-1 SEMAGLUTIDE MEDICATIONS
Rise Up with Orriant
36 minutes 1 second
2 months ago
SEASON 6 - EPISODE 8: THE TRUTH ABOUT GLP-1 SEMAGLUTIDE MEDICATIONS

Ozempic, Wegovy, & Other Semaglutide medications are some of the hottest medications on the market today. Join our GLP-1 expert, Rachel Derylo, who will explain the effects of GLP-1s on the body and set the narrative on the proper use of these medications. We will discuss strategies to mitigate being under-muscled which is a common and chronic health issue. Together we will step into autonomy over your health with the tool of GLP-1s.

Rise Up with Orriant
Join Orriant for a journey through wellbeing and population health trends and conversations. Our speakers are national experts in their fields, assisted by Orriant's best-in-class health coaches.